Home
Onesource Specialty Pharma Ltd Share Price History
OneSource Specialty Pharma Ltd
NSE : 03 Mar, 2025
1326.7588.6 (7.2%)
Prev Close
1238.2
Open Price
1241.9
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
356308
Today's High / Low
1348.8 / 1209.9
52 WK High / Low
1800.0 / 1209.9
Market Price of OneSource Specialty Pharma Ltd
1M
1Y
3Y
5Y
Monitoring OneSource Specialty Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2020 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | -1479.22 |
| YoY Gr. | - |
| Net Profit (Cr.) | -140 |
| BVPS | 4386.31 |
Key Financial Parameters
| Parameter | 2020 |
|---|---|
| Return on Capital Emp. % | 0 |
| Op. Profit Mgn % | -5401.95 |
| Net Profit Mgn % | -9077.27 |
| Debt to Equity % | 1.14 |
Latest Shareholding
Promoters Holdings Over Time
About OneSource Specialty Pharma Ltd
- Onesource Specialty Pharma Limited was incorporated as a Private Limited Company, with the name and style of Inbiopro Solutions Private Limited' dated June 12, 2007, was issued by the Registrar of Companies, Karnataka at Bangalore.
- The Company name was then changed to Stelis Biopharma Private Limited', pursuant to a Scheme of Amalgamation and a Certificate of Incorporation dated December 24, 2014, was issued by the Registrar of Companies.
- The status of the Company was then converted from a Private Limited Company to a Public Limited Company, and renamed as Stelis Biopharma Limited' dated July 31, 2021,.
- Subsequently, the name was changed to its present Onesource Specialty Pharma Limited' on February 13, 2024, and a fresh Certificate of Incorporation dated February 13, 2024, was issued by the Registrar of Companies, Karnataka at Bangalore.
Popular Search
FAQs for OneSource Specialty Pharma Ltd Share Price History
What are the key events that typically impact OneSource Specialty Pharma Ltd's share price history?
Key events that impact OneSource Specialty Pharma Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect OneSource Specialty Pharma Ltd's share price history?
Stock splits reduce the nominal price of OneSource Specialty Pharma Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of OneSource Specialty Pharma Ltd?
Dividends can influence OneSource Specialty Pharma Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect OneSource Specialty Pharma Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on OneSource Specialty Pharma Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand OneSource Specialty Pharma Ltd’s share price history?
To understand OneSource Specialty Pharma Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
